Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
Clinical trial NCT01471782 · COMPLETED
Trial details
- NCT number
- NCT01471782
- Sponsor
- Amgen Research (Munich) GmbH
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2014-08-01
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.